Literature DB >> 27387643

Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration.

Henrik Zetterberg1.   

Abstract

In the current issue of Neuron, Bacioglu, Maia, and colleagues show that neurofilament light concentrations in body fluids reflect pathology and symptoms in mouse models of cerebral proteopathies and that these findings translate to human disease (Bacioglu et al., 2016).
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27387643     DOI： 10.1016/j.neuron.2016.06.030

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  55 in total

1.  Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study.

Authors:  Carlo Wilke; Friedemann Bender; Stefanie N Hayer; Kathrin Brockmann; Ludger Schöls; Jens Kuhle; Matthis Synofzik
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

Review 2.  Applying fluid biomarkers to Alzheimer's disease.

Authors:  Henrik Zetterberg
Journal:  Am J Physiol Cell Physiol       Date:  2017-04-19       Impact factor: 4.249

Review 3.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

4.  Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery: Results From the CAPACITY and ARCADIAN Studies.

Authors:  Lisbeth Evered; Brendan Silbert; David A Scott; Henrik Zetterberg; Kaj Blennow
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

5.  Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.

Authors:  Elizabeth E Moore; Katherine A Gifford; Omair A Khan; Dandan Liu; Kimberly R Pechman; Lealani Mae Y Acosta; Susan P Bell; Maxim Turchan; Bennett A Landman; Kaj Blennow; Henrik Zetterberg; Timothy J Hohman; Angela L Jefferson
Journal:  Alzheimers Dement       Date:  2020-05-06       Impact factor: 21.566

6.  CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.

Authors:  Julio C Rojas; Jee Bang; Iryna V Lobach; Richard M Tsai; Gil D Rabinovici; Bruce L Miller; Adam L Boxer
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

7.  Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.

Authors:  Melissa E Petersen; Michael S Rafii; Fan Zhang; James Hall; David Julovich; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Tatiana Foroud; Florence Lai; H Diana Rosas; Shahid Zaman; Mei-Cheng Wang; Benjamin Tycko; Joseph H Lee; Benjamin Handen; Sigan Hartley; Juan Fortea; Sid O'Bryant
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.

Authors:  Magnus Gisslen; Sheila M Keating; Serena Spudich; Victor Arechiga; Sophie Stephenson; Henrik Zetterberg; Clara Di Germanio; Kaj Blennow; Dietmar Fuchs; Lars Hagberg; Philip J Norris; Julia Peterson; Barbara L Shacklett; Constantin T Yiannoutsos; Richard W Price
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

9.  Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy.

Authors:  Tomohiro Hayashi; Takamasa Nukui; Jin-Lan Piao; Tomoyuki Sugimoto; Ryoko Anada; Noriyuki Matsuda; Mamoru Yamamoto; Hirofumi Konishi; Nobuhiro Dougu; Yuji Nakatsuji
Journal:  Brain Behav       Date:  2021-02-22       Impact factor: 2.708

10.  Seven day pre-analytical stability of serum and plasma neurofilament light chain.

Authors:  Patrick Altmann; Markus Ponleitner; Paulus Stefan Rommer; Helmuth Haslacher; Patrick Mucher; Fritz Leutmezer; Axel Petzold; Christoph Wotawa; Rupert Lanzenberger; Thomas Berger; Henrik Zetterberg; Gabriel Bsteh
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.